Magnesium-Diasporal 300 pro
Magnesium-Diasporal 300 pro is a medicine authorised by Swissmedic under authorisation number 60538. The authorisation holder is Doetsch Grether AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 15 February 2011 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 60538 |
|---|---|
| Name | Magnesium-Diasporal 300 pro |
| Full name | Magnesium-Diasporal 300 pro, Granulat |
| Authorisation holder | Doetsch Grether AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | not stated |
| First authorisation | 15 February 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Magnesium-Diasporal 300 pro, Granulat | D | 15 February 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Magnesium-Diasporal 300 pro authorised in Switzerland?
Yes. Magnesium-Diasporal 300 pro is authorised by Swissmedic under authorisation number 60538, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Magnesium-Diasporal 300 pro have?
Magnesium-Diasporal 300 pro is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Magnesium-Diasporal 300 pro?
The authorisation holder is Doetsch Grether AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.